Nemaura Medical, Inc. Common Stock
NMRD
NMRD was delisted on the 4th of January, 2024.
5 hedge funds and large institutions have $21K invested in Nemaura Medical, Inc. Common Stock in 2018 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 3 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
17% less funds holding
Funds holding: 6 → 5 (-1)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
84% less capital invested
Capital invested by funds: $133K → $21K (-$112K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$10.8K |
| 2 |
WAS
WESPAC Advisors SoCal
Pasadena,
California
|
+$5.78K |
| 3 |
CFGS
Concourse Financial Group Securities
Birmingham,
Alabama
|
+$3.73K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PGCM
Prescott Group Capital Management
Tulsa,
Oklahoma
|
-$44K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$27K |
| 3 |
VF
Virtu Financial
New York
|
-$24K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$430 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SC
1
Scotia Capital
Toronto,
Ontario, Canada
| $11K | – | – | – |
|
|
2
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $5K | +$10.8K | +601 | +2,003% |
|
|
3
UBS Group
Zurich,
Switzerland
| $2K | -$430 | -24 | -9% |
|
|
WAS
4
WESPAC Advisors SoCal
Pasadena,
California
| $2K | +$5.78K | +323 | New |
|
|
CFGS
5
Concourse Financial Group Securities
Birmingham,
Alabama
| $1K | +$3.73K | +208 | New |
|
|
PGCM
6
Prescott Group Capital Management
Tulsa,
Oklahoma
| – | -$44K | -1,850 | Closed |
|
|
7
Citadel Advisors
Miami,
Florida
| – | -$27K | -1,139 | Closed |
|
|
VF
8
Virtu Financial
New York
| – | -$24K | -1,026 | Closed |
|
NMRD Hedge Fund Activity: Q4 2018 in Review
5 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Nemaura Medical, Inc. Common Stock (NMRD) for Q4 2018, worth a combined $21K — down 84% from $133K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of NMRD and 2 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 1 added.
The largest buyer was Deutsche Bank, adding an estimated $10.8K. The largest seller was Prescott Group Capital Management, exiting entirely with an estimated $44K sold.
- 5 institutional investors held Nemaura Medical, Inc. Common Stock (NMRD) as of Q4 2018, down from 6 in Q3 2018.
- Funds reported $21K of Nemaura Medical, Inc. Common Stock stock for Q4 2018, down 84% quarter-over-quarter.
- 2 funds opened new Nemaura Medical, Inc. Common Stock positions in Q4 2018 and 3 closed out, a net change of -1 holder.
- The largest Nemaura Medical, Inc. Common Stock buyer in Q4 2018 was Deutsche Bank, an estimated $10.8K added.
- The largest Nemaura Medical, Inc. Common Stock seller in Q4 2018 was Prescott Group Capital Management, an estimated $44K sold.
Based on aggregated 13F filings for Q4 2018.